Bernard Coulie, President and CEO: Pliant Therapeutics PLRX Sell · Filed 24/01/19

Trade details

Type: Insider sale
Amount: $443,172.83
Shares · price: 25,721 sh · $17.23 a share
Held after: 316,382 sh
Stock: Pliant Therapeutics PLRX
Person: Bernard CouliePresident and CEO
Trade date: 24/01/17
Filed: 24/01/19
Days to filing: 2 days

Sold 7.5% of holdings

Share of holding sold: 7.5%

Pliant Therapeutics trades, last 26 weeks

What else happened in Pliant Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/18~24/02/16

Bernard Coulie's recent trades

Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$114.4K
89,375 sh
$114.4K
Filed 01/22
Traded 01/20
Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$587.1K
52,419 sh
$587.1K
Filed 25/01/22
Traded 25/01/17
Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$447.5K
38,710 sh
$447.5K
Filed 24/07/12
Traded 24/07/10
Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$1.3M
70,150 sh
$1.3M
Filed 23/07/19
Traded 23/07/17
Bernard CouliePresident and CEO
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$937.2K
35,339 sh
$937.2K
Filed 23/04/03
Traded 23/03/30